Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: Reduction of erythropoietin dose in 4 years of follow-up

Background : : Ferric carboxymaltose (FCM) is a parenteral, dextran-free iron formulation designed to overcome the limitations of existing iron preparations. The main aim of this study was to retrospectively examine results obtained from a long period of FCM therapy in hemodialysis patients who have...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Antonio Lacquaniti (Author), Patrizio Pasqualetti (Author), Teresa Casuscelli di Tocco (Author), Susanna Campo (Author), Stefania Rovito (Author), Maurizio Bucca (Author), Antonino Ragusa (Author), Paolo Monardo (Author)
Format: Knjiga
Izdano: The Korean Society of Nephrology, 2020-09-01T00:00:00Z.
Teme:
Online dostop:Connect to this object online.
Oznake: Označite
Brez oznak, prvi označite!

Internet

Connect to this object online.

3rd Floor Main Library

Podrobnosti zaloge 3rd Floor Main Library
Signatura: A1234.567
Kopija 1 Prosto